Clinical trials show progress in migraine frequency, skin cancer prevention
-
6:01
CBS 58, Hunger Task Force team up for 2026 Drive-Thru Food Drive...
-
3:31
’Absolutely a monster’: Milwaukee man convicted in murder...
-
2:37
Where to find the cheesiest gifts this holiday season
-
3:45
Milwaukee holiday tree lighting brings Santa, Bango and free...
-
2:27
Winter Weather Awareness Week wraps up with record warmth
-
2:33
Protests in Madison after decision not to charge officer who...
-
2:09
’Do I hold out hope?’: Children’s Wisconsin, Anthem negotiation...
-
2:10
CBS 58 Hometowns LIVE: Milwaukee Holiday Lights Festival
-
1:42
Lomira defeats Mondovi to win 2nd Division 6 state title in 3...
-
0:44
Lead hazard reduction work expected to be completed in more than...
-
3:41
Near record high temps to end the week
-
1:07
Historic marker dedicated at site of Wisconsin’s oldest gay...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.